Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials
Charles C. Wykoff
, Michael J. Elman
, Carl D. Regillo
, Beiying Ding
, Na Lu
, Ivaylo Stoilov
Research output: Contribution to journal › Article › peer-review
51Scopus
citations
Fingerprint
Dive into the research topics of 'Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science